Virtus ETF Advisers’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$161K Buy
30,641
+1,473
+5% +$7.75K 0.06% 311
2026
Q1
$122K Hold
29,168
0.06% 311
2025
Q4
$140K Hold
29,168
0.07% 295
2025
Q3
$148K Buy
+29,168
New +$129K 0.08% 252

Other funds holding SRTA

Virtus ETF Advisers's SRTA Position: Q2 2026 in Review

Virtus ETF Advisers increased its Strata Critical Medical Inc (SRTA) stake by 5.1% in Q2 2026, buying an estimated $7.75K and bringing the position to 30,641 shares worth $161K. The position accounts for 0.06% of the portfolio, ranked #311.

Virtus ETF Advisers first reported a position in SRTA in Q3 2025 and has held it in 4 quarters since. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Virtus ETF Advisers held 30,641 shares of Strata Critical Medical Inc worth $161K as of Q2 2026.
  • Virtus ETF Advisers bought 1,473 Strata Critical Medical Inc shares in Q2 2026, an estimated $7.75K.
  • Strata Critical Medical Inc made up 0.06% of Virtus ETF Advisers's portfolio in Q2 2026, its #311 holding.
  • Virtus ETF Advisers first reported a position in Strata Critical Medical Inc in Q3 2025 and has held it in 4 quarters since.
  • 139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.